Wasatch Advisors LP Activity Analysis: Q3 2026 Portfolio Shifts

As part of its investment strategy, Wasatch Advisors Lp, a significant investor with substantial holdings as of June 30th, 2026, has recently adjusted its portfolio. This review focuses on the notable changes observed in their investment activities during this period.

Several companies saw Wasatch increase their stake significantly during Q3 2026:

• CCC SN: The position grew by a massive 44.93%, adding substantial value to the Technology sector allocation.
• FLYW: This new holding increased by an impressive 100%, indicating strong confidence in this recently acquired position within Technology stocks.
• CTS: The investor purchased shares, boosting their stake by approximately 80.53% during the quarter.

• ESPR: The position in Esperion Therapeutics decreased by an astronomical 87.76%, suggesting a significant decision to sell these holdings.
• CERS: A notable sale occurred with Cerus Corp, seeing a reduction of about 35.92% in the position during Q3.

Furthermore, Wasatch initiated new positions and scaled back others:

• CCCS: A substantial increase of 45.87% in holdings.
• AESI: Purchased shares, establishing a new position or increasing an existing one by 100% during the quarter.
• OZK: Holdings decreased, reflecting a reduction in exposure to this Financial Services holding.

The investor also demonstrated activity with other stocks:

• LPRO saw its stake reduced by 30.94%.
• HMN, Horace Mann Educators Corp, experienced a decrease of 100% in its position.
• FOUR, SHIFT4 PMTS INC, also faced a reduction of 48.43% during the quarter.

The overall portfolio shows diversification across various sectors including Technology (13.44%), Healthcare (17.51%), and Financial Services (13.5%). The changes observed in Q3 reflect Wasatch's dynamic investment approach, balancing new opportunities with strategic exits.